Velesco Pharma has initiated operations at its new state-of-the-art cGMP clinical manufacturing facility in Wixom, MI. The newly renovated building triples the company’s cGMP clinical trial manufacturing capacity, and will feature expanded processing suite space to manufacture a range of non-sterile dosage forms including liquids, semi-solids, powders, capsules and tablets. The facility also has the capability to handle high potency compounds. Peter Angus, vice president of Research at Vel...